The ulceration‐associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland
- 1 August 1994
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 173 (4) , 317-326
- https://doi.org/10.1002/path.1711730406
Abstract
The ulceration‐associated cell lineage (UACL) develops in the human gastrointestinal mucosa after ulceration; it grows out from the bases of adjacent crypts and ramifies in the lamina propria to form a new gland, finally giving rise to a duct by which the glandular secretion and indeed cells are carried to the surface. Using immunocytochemistry and in situ hybridization with 35S‐labelled riboprobes, we have defined the pattern of trefoil peptide gene expression (pS2; human spasmolytic polypeptide, hSP), epidermal growth factor/urogastrone (EGF/URO), and the distribution of cell proliferation during the development of the UACL, as indicated by immunostaining for proliferating cell nuclear antigen (PCNA). Our studies reveal that the morphogenesis of the UACL shows a marked morphological resemblance to developing Brunner's glands; the pattern of trefoil peptide gene expression during UACL development is also very similar. However; trefoil peptide gene expression in the mature UACL complex is unique amongst gastrointestinal cells. The mature UACL shows a distinctive proliferative organization: while the early buds and glands are non‐proliferative, apparently being fed by cells from the parent crypts, a definitive proliferative zone develops within the duct. This, of course, corresponds to the location of the gastric gland proliferative zone. We propose that while the UACL shows novel features, it shares its differentiation programme with Brunner's glands, but its pattern of cell renewal eventually is that of the gastric gland.Keywords
This publication has 35 references indexed in Scilit:
- Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasmsThe Journal of Pathology, 1990
- Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissuesThe Journal of Pathology, 1990
- Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cellsNature, 1990
- Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cellsFEBS Letters, 1989
- Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats.Gut, 1987
- On the Role of Epidermal Growth Factor in the Defence of the Gastroduodenal MucosaScandinavian Journal of Gastroenterology, 1987
- INTRAVENOUS EPIDERMAL GROWTH FACTOR/UROGASTRONE INCREASES SMALL-INTESTINAL CELL PROLIFERATION IN CONGENITAL MICROVILLOUS ATROPHYThe Lancet, 1985
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Epidermal growth factor‐like material in rat submandibular glandJournal of Anatomy, 1979
- Pyloric metaplasia in the small intestineThe Journal of Pathology and Bacteriology, 1964